68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 30, 2022

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Advanced Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8Stage IV Hepatocellular Carcinoma AJCC v8Unresectable Hepatocellular Carcinoma
Interventions
PROCEDURE

Computed Tomography

Undergo 68Ga PSMA PET/CT

DRUG

Gallium Ga 68 Gozetotide

Undergo 68Ga PSMA PET/CT

PROCEDURE

Positron Emission Tomography

Undergo 68Ga PSMA PET/CT

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05176223 - 68Ga PSMA PET Imaging for the Treatment of Advanced Liver Cancer | Biotech Hunter | Biotech Hunter